XPEL’s Record Revenue Hides a 16% Annual Drop

On August 5, 2026, XAN rose by 0.91% within 24 hours to reach $0.013871. XAN rose by 25.03% within 7 days, rose by 25.03% within 1 month, and dropped by 16.16% within 1 year.

Financial Performance and Revenue Growth

XPEL, Inc. reported record revenue of $143.1 million for the second quarter of 2026, marking a revenue growth of 14.7% compared to the previous period. This financial expansion was primarily driven by the company’s strategic manufacturing investments established in San Antonio and China. The preliminary and unaudited results for 2026 reflect these operational successes, with full financial details scheduled for inclusion in the Company’s Quarterly Report on Form 10-Q with the Securities and Exchange Commission, anticipated on or prior to August 7, 2026. As the quarter-end financial close processes finalize, adjustments to the preliminary information may occur, though the current data highlights significant top-line growth.

Strategic Outlook and Projections

Looking ahead to the third quarter of 2026, the Company has established a revenue forecast. Analysts project third quarter 2026 revenue to be approximately between $137 million and $139 million. This guidance provides a clear benchmark for upcoming performance, subject to the cautionary statements regarding forward-looking statements inherent in corporate disclosures. The company’s dedication to exceeding customer expectations through high-quality products, expert technical support, and world-class training continues to underpin its market position as a leading provider of protective films and coatings, including automotive paint protection film and ceramic coatings.

Market Context and Related Corporate Updates

While XAN’s price action is the primary focus, the broader market landscape on August 5, 2026, featured significant corporate developments from other entities. Angel reported second-quarter 2026 results with a notable 99.2% year-over-year climb in Guild membership. The company highlighted a reduction in year-to-date Adjusted EBITDA loss to $7.7 million in the first half of 2026, down from $46.2 million in the prior year. Angel reiterated guidance to reduce its full-year 2026 Adjusted EBITDA loss to no more than $25 million, with seven theatrical releases slated for the second half of the year to drive further membership growth.

In the biopharmaceutical sector, Ultragenyx reported a net loss of $92 million, or $0.90 per share, for the second quarter of 2026, an improvement from the $115 million loss recorded in the same period of 2025. The company maintained a cash balance of $436 million as of June 30, 2026. Ultragenyx reaffirmed its full-year 2026 and 2027 guidance, expecting combined R&D and SG&A expenses in 2026 to be flat to down low-single digits compared to 2025, and a decrease of at least 15% in 2027.

Meanwhile, Icahn Enterprises reported Q2 2026 revenue of $3.0 billion, alongside a net loss of $355 million and an Adjusted EBITDA loss of $134 million. In the technology sector, 8x8, Inc. announced record revenue for the first quarter of fiscal year 2027, highlighting innovations in enterprise-grade intelligence and automation, including new AI routing capabilities and platform integrations.

Navigator Gas provided preliminary second-quarter 2026 results, noting its equity method investments in Azane Fuel Solutions and Unigas International B.V. The company increased its interest in Azane to 16.1% in June 2026, focusing on green ammonia fuel handling technologies. These diverse corporate activities underscore a dynamic market environment, yet XAN’s specific trajectory remains anchored to its immediate price movement of 0.91% for the day.